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At Risk for Huntington's Disease
HD is a genetically caused brain disorder that causes uncontrollable bodily movements and robs
people's ability to walk, talk, eat, and think. The final result is a slow, ugly death. Children of parents
with HD have a 50-50 chance of inheriting the disease. There is no cure or treatment.
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Hope, cutting-edge science, and poignant moments
at the World Congress on Huntington’s Disease

The first such HD meeting held in a developing nation, last
month’s World Congress on Huntington’s Disease (WCHD)
not only highlighted the need for better understanding of the
disease in Latin America. It also revealed the growing global
importance of the the quest for both better care everywhere
and the development of treatments.
Featuring activities for both researchers and families, the
sixth WCHD featured some 20 panels, a poster session, a
satellite symposium, joint meetings of the International
Huntington Association (IHA) and the Associação Brasil
Huntington (ABH), entertaining evening wrap-ups by
HDBuzz.net editors Dr. Jeff Carroll and Dr. Ed Wild, and a
moving presentation by the France-based HD performance
group Dingdingdong.
Like most HD conferences, the WCHD stressed advances in
the search for treatments. The four-hour-long closing
session included an update on clinical trials, a talk on deep
brain stimulation and HD, a presentation on cutting-edge
RNA-interference-based (RNAi) therapies, and an overview
of the efforts to reduce or block the deleterious effects of the
faulty protein huntingtin in the brain.
“There is a lot of hope,” said Dr. Doug Macdonald, the
director of drug discovery and development for CHDI
Management, Inc., which directs the multi-million-dollar
effort to defeat HD by the CHDI Foundation, Inc., in his
presentation. “There is a rich pipeline of these therapeutics
advancing into the clinic. We have direct delivery of
huntingtin-lowering agents, the viral delivery of RNAi
agents, and viral delivery of zinc finger protein agents.”
Dr. Macdonald provided a clinical-trial timeline for these
potential drugs. The first is likely to be the huntingtinlowering drug under development at Isis Pharmaceuticals,
Inc., and Roche, scheduled to enter a Phase I trial by the end
of 2014. Other projects may begin trials in the next few
years, Dr. Macdonald added.
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For a detailed explanation of these approaches and more on
timelines, watch Dr. Macdonald’s talk in its entirety in the
video below. See also a discussion of other types of trials and
general coverage of the WCHD at www.HDBuzz.net.
You can view 32 more chronologically ordered conferencerelated videos by visiting my 2013 World Congress on
Huntington’s Disease album on Vimeo.

Modulating Huntingtin Levels to Treat
Huntington's Disease: A Talk by Dr.
Doug Macdonald
from Gene Veritas
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Dance
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Disease Page

22:56

Modulating Huntingtin Levels to Treat Huntington's
Disease: A Talk by Dr. Doug Macdonald from Gene Veritas
on Vimeo.
From exciting science to social consequences
The WCHD scientific presenters focused on a panoply of
other HD themes, from exciting developments in basic
science to current medical treatments of symptoms to the
social consequences of HD.
Dr. Elena Cattaneo of Italy presented the latest research on
the origins of the huntingtin gene.
“The normal gene is a gene that everyone has,” Dr. Cattaneo
explained. “Everyone in the world has that gene. At some
point, we started to think that, if we have that gene, it means
that gene is important. So about ten years ago my group, but
also other groups, started looking for the function of the
normal gene. Of course, we know that in the disease the
mutant gene causes the loss of the neurons. But in order to
understand more about the mutant version, we wanted to
understand what the normal version was doing.”
Scientists discovered that the normal gene is important for
“keeping the neurons healthy and alive and working
properly,” she said.
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The huntingtin gene was “born” in an ameba species 800
million years ago, she continued. “This is the first
pluricellular organ, and the huntingtin gene is there.
Pluricellular means that cells talk to each other to form an
organism…. I started thinking of huntingtin as a gene with a
social function, because it brings cells together. So let’s
assume that huntingtin is such a gene. Huntingtin is a good
gene. It is not a bad gene.”
You can watch Dr. Cattaneo’s fascinating presentation in the
video below.

The Role of the Huntingtin Gene in
Huntington's Disease: A Presentation
by Dr. Elena Cattaneo
from Gene Veritas

22:01

The Role of the Huntingtin Gene in Huntington's Disease: A
Presentation by Dr. Elena Cattaneo from Gene Veritas on
Vimeo.
Other notable presentations included Portuguese Dr.
Joaquim Ferreira’s detailed review of the various ways in
which doctors treat patients and Dr. Anita Goh’s discussion
of genetic discrimination and HD.
The Latin American perspective
The WCHD brought a key South American perspective on
HD.
“For one thing, the participation of a number of Latin
American neurologists, geneticists, and family members
offered some new views of Huntington's disease in countries
such as Brazil, Peru, Argentina, and Colombia – countries
we often do not hear about at international HD meetings,”
Dr. Alice Wexler, a historian of HD science, observed in an
e-mail after the congress. “Because the extent of
Huntington's in these countries is not well known, many of
these researchers presented epidemiological and
demographic information that was new to most HD
researchers, along with clinical and genetic data.”
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Dr. Robert Weiser of Venezuela provided a view of HD in
Maracaibo, Venezuela, the world’s largest known
concentration of HD patients, while Dr. Carlos Cosentino of
Peru and Dr. Laura Jardim of Brazil presented their unique
research on other aspects of HD in the region.
The WCHD highlighted a stark contrast between the First
World, where many HD patients can consult with physicians
in modern clinics, and Latin America, where large pockets of
HD-affected individuals get no medical attention and lack
even such basics as clean drinking water.
Several participants noted that such conditions must
improve dramatically for these families to take part in the
studies and clinical trials crucial for finding treatments,
including Enroll-HD, discussed below.
Rodrigo Osorio of Chile and Alice Wexler’s sister Dr. Nancy
Wexler of the U.S. gave moving testimony regarding some of
the efforts in the region to improve the conditions for
patients, while Dr. Ignacio Muñoz-Sanjuan of CHDI
advocated for a recently launched charitable, medical, and
care initiative serving Latin America called Factor H: Hope,
Huntington’s, Humanity. In their interview with me in
Spanish, activists Aleska González and Vivian Puchi
elaborated on the major challenges facing the HD
community in their native Venezuela.
You can watch Muñoz-Sanjuan describe Factor H in the
video below.

Factor H: Hope, Huntington's,
Humanity
from Gene Veritas

30:03

Factor H: Hope, Huntington's, Humanity from Gene Veritas
on Vimeo.
Riveting stories
The WCHD also gave voice to the riveting stories of HD
patients, tested and untested at-risk individuals, caregivers,
curehd.blogspot.com/2013/10/hope-cutting-edge-science-and-poignant.html
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and family members.
I participated in a plenary session titled “Coping.” The
session began with a troubling presentation by Dutch Ph.D.
student Marlous Hubers on the topic of “suicidality in
Huntington’s disease.”
“In general, suicide occurs two to eight times more often in
Huntington’s disease than in the general population,”
Hubers stated. “In general, it’s said that 5.7 percent of all
deaths in HD are due to suicide, which makes it the third or
fourth cause of death in HD…. Screening for suicidal
ideation is most important in patients with a depressed
mood, as all studies found it as an important predictor.”
Shaken by Hubers’ incisive data, I started my own
presentation on coping, which followed hers, by observing
that “Marlous’s extremely important research really brings
home some issues for me. It brings up lots of memories of
how I’ve been trying to cope with living gene-positive for
Huntington’s disease. I think she hit the nail right on the
head with respect to how gene carriers need help, and gene
carriers are kind of on their own, not only with respect to
suicide, but other aspects of the disease.”
Collecting myself, I proceeded with a detailed rundown of
the many strategies I have adopted to avoid the onset of
symptoms.
You can watch my presentation in its entirety in the video
below.

Coping with the Threat of
Huntington's Disease: Gene Veritas
speaks at the World Congress on HD
from Gene Veritas

33:17

Coping with the Threat of Huntington's Disease: Gene
Veritas speaks at the World Congress on HD from Gene
Veritas on Vimeo.
In one of the most poignant moments of the WCHD, Dr.
Carroll and his wife Megan revealed how they conceived
curehd.blogspot.com/2013/10/hope-cutting-edge-science-and-poignant.html
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their HD-free twins, a boy and a girl, using PGD,
preimplantation genetic diagnosis.
The topic was particularly striking for Latin Americans.
Genetic testing and genetic counseling are still a rarity, and
it’s unclear how much people know about PGD or have used
it. In addition, abortion is illegal throughout most of the
region, and, at least in the Brazilian case, legislation against
genetic discrimination is lacking.
Watch the Carrolls discuss PGD and hear the audience
discussion in the video below.

Preimplantation Embryo Selection:
Avoiding the Transmission of
Huntington's Disease
from Gene Veritas

18:30

Preimplantation Embryo Selection: Avoiding the
Transmission of Huntington's Disease from Gene Veritas on
Vimeo.
From young people, with love
The WCHD also had a strong youth presence. I interviewed
England-based Matty Ellison, the 25-year-old founder of the
Huntington’s Disease Youth Organization, about his father’s
fight against HD, his own experience of testing positive for
the gene at the age of 19, and his international advocacy.
The most unusual and beautiful moment of the WCHD came
with the performance of Dingdingdong, a group of young
adult performers representing French HD families and
reflecting many themes relevant to young people facing HD.
The group put on From Huntingtonland with Love, a threepart presentation in English involving a short play, a video,
and a silent dance performance by chogeographer and
dancer Anne Collod, in which she mimics the chorea, or
involuntary, dance-like movements, suffered by most HD
patients.
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You can watch Collod in the video below.

A Portrait in Motion of D., a Man
Suffering from Huntington's Disease
from Gene Veritas

04:27

A Portrait in Motion of D., a Man Suffering from Huntington's Disease
from Gene Veritas on Vimeo.

A costly event
For me, one drawback of the WCHD was the high cost of the
venue, the Sheraton Rio Hotel and Resort, a luxury-class
facility on the beach of Leblon, one of the world’s most
expensive neighborhoods. My room cost nearly $400 per
night, the most expensive room I have ever paid for, and out
of reach for vast numbers of Latin American families. (And I
couldn’t even share that expensive room with my wife, since
she was back home with our daughter.)
Along with several family advocates and others, I noted how
the exclusive facility, as well as the scheduling of the event
the same week as the Rock in Rio music festival, had made it
extremely difficult for low and even middle-income families
– and perhaps also local research students – to take part.
As an experienced Brazil hand, I thought the organizers
might have chosen less expensive, more accessible facilities.
In my opinion, holding the meeting in less-glamorous but
more convenient São Paulo – where ABH headquarters are
located – would have been a good option.
Dozens of Brazilians attended the WCHD, but only a handful
of people came from other countries, even from the
aforementioned world leader in HD patients, Venezuela.
Nevertheless, as I wrote in my previous article, overall I
thought the WCHD ran very smoothly, and families and IHA
made important new connections.
A boost to Enroll-HD
curehd.blogspot.com/2013/10/hope-cutting-edge-science-and-poignant.html
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Following the WCHD, CHDI ran a seminar to train medical
professionals from Argentina, Brazil, Colombia, and
Venezuela how to evaluate HD patients and collect medical
information on them for Enroll-HD, the recently
inaugurated global HD observational study and database.
Enroll-HD aims to improve tools to assess the disease,
identify and characterize biomarkers (signs of the disease)
necessary for measuring the effectiveness of treatments,
recruit participants for other studies and trials, and improve
clinical care everywhere.
Featuring Enroll-HD on one of its panels, the WCHD in Rio
provided an important moment for publicizing the program
and attracting participants.
(I will report on Enroll-HD at the WCHD in a future article.)
Continuing to foster international connections – and greater
family participation in future conferences at all levels – will
increase the chances of success of Enroll-HD and ultimately
the defeat of HD.
Posted by Gene Veritas at 9:07 PM
Labels: Brazil , CHDI , Elena Cattaneo , genetic discrimination , huntingtin ,
Huntington's disease , Latin America , Maracaibo , researcher , RNA interference ,
science , treatments , World Congress on Huntington's Disease

1 comment:
Anonymous said...
Thank you so much Gene...for those of us waiting...and
waiting...and waiting. In 1993 we were told that since the gene
had been discovered, there would be a CURE within 8-10 years
at the most. Then there was "shock and awe" and two wars for
which no one is counting the fatalities that have occurred
because of all those billions and trillions of dollars going
toward fighting them rather than toward research and the
finding of cures not only for HD, but cancer, ALS, MS, and ALL
the others. Do politicians know the anguish they are causing
generations (3 in our case so far plus at-risk kids) of good
families by not funding research and development?
8:21 PM, October 08, 2013
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